En esta página
01QNCX precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
QNCX Quince Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 14, 2026
$29,20
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$15,10mínimo 52 semanas
$910,00máximo 52 semanas
Capitalización Bursátil (MRQ)
$30M
P/E
-0.2
BPA
$-1.68
tus insignias
Rango 52S
$15–$910
Calificación del Analista
BUY
Precio Objetivo
$75
P/E
-0.2
ROE
700.5%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
QNCX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$29.20
Capitalización Bursátil (MRQ)
$30M
P/E
-0.2
BPA
$-1.68
ROE
700.5%
Deuda/Capital (MRQ)
-0.0
Rango 52S
$15–$910
QNCX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 30 de junio de 2026 | 1-for-20 | Inversa |
| 13 de abril de 2026 | 1-for-10 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-1.682021-12-31 → 2025-12-31
Flujo de caja libre$-42M2019-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | QNCX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.2promedio 5A ≈-1.9 | ≈-1.9 | · | · | |
| P/C (MRQ) | -0.8promedio 5A ≈0.3 | ≈0.3 | · | · | |
| EV / EBITDA | -0.6 | · | · | · | |
| Precio / FCF (TTM) | -0.6promedio 5A ≈-3.2 | ≈-3.2 | · | · | |
| Precio / Flujo de Caja (TTM) | -0.6promedio 5A ≈-3.2 | ≈-3.2 | · | · | |
| EV / FCF (TTM) | 1.8 | · | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -0.8promedio 5A ≈5.1 | ≈5.1 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | QNCX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -80.8%promedio 5A ≈-48.7% | ≈-48.7% | -103.8% | De primer nivel | |
| ROE | 700.5%promedio 5A ≈78.0% | ≈78.0% | -323.9% | De primer nivel | |
| ROIC | 341.4%promedio 5A ≈14.7% | ≈14.7% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | QNCX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | -0.0 | · | · | · | |
| Ratio corriente (MRQ) | 14.5promedio 5A ≈10.6 | ≈10.6 | 1.6 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 0.1promedio 5A ≈10.1 | ≈10.1 | 1.4 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-18.9%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 14, 2026 | $-12.31 | $-18.24 | 32.5% |
| 31 de marzo de 2026 | May 11, 2026 | $57.60 | $-52.22 | 210.3% |
| 31 de diciembre de 2025 | $-142.00 | $-38.52 | -268.7% | |
| 30 de septiembre de 2025 | $-50.00 | $-44.15 | -13.3% | |
| 30 de junio de 2025 | $-46.00 | $-51.34 | 10.4% | |
| 31 de marzo de 2025 | $-3.40 | $-2.32 | -46.5% | |
| 31 de diciembre de 2024 | $-0.28 | $-0.18 | -56.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $35M | $19M | $9M | $25M | $61M | $61M | $30M | $10M | |
| SG&A Expense | $15M | $18M | $18M | $26M | $30M | $18M | $9M | $2M | |
| Operating Expenses | $58M | $57M | $35M | $52M | $90M | $79M | $39M | $12M | |
| Operating Income | $-58M | $-57M | $-35M | $-52M | $-90M | $-79M | $-39M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | $957.0K | |
| Interest Income | $1M | $3M | $3M | $1M | $620.0K | $2M | $2M | $806.0K | |
| Other Non-op | $486.0K | $-676.0K | $-102.0K | $-997.0K | $-247.0K | $0 | $0 | · | |
| Pretax Income | $-81M | $-57M | $-32M | $-52M | $-90M | $-77M | $-37M | · | |
| Income Tax | $3M | $87.0K | $-197.0K | $-284.0K | $0 | $0 | $0 | $0 | |
| Net Income | $-84M | $-57M | $-31M | $-52M | $-90M | $-77M | $-37M | $-12M | |
| EPS (Basic) | $-1.68 | $-1.31 | $-0.84 | $-1.54 | $-3.03 | · | · | · | |
| EPS (Diluted) | $-1.68 | $-1.31 | $-0.84 | $-1.54 | $-3.03 | · | · | · | |
| Shares (Basic) | 50,096,897 | 43,262,269 | 37,237,149 | 33,496,534 | 29,718,506 | · | · | · | |
| Shares (Diluted) | 50,096,897 | 43,262,269 | 37,237,149 | 33,496,534 | 29,718,506 | · | · | · | |
| EBITDA | $-58M | $-57M | $-35M | $-52M | $-90M | $-79M | $-39M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $6M | $75M | $41M | $29M | $134M | $51M | $25M | |
| Short-term Investments | $12M | · | · | · | · | · | · | · | |
| Receivables | · | · | · | $0 | · | · | · | · | |
| Prepaid Expense | $5M | $3M | $2M | $4M | $5M | $4M | $6M | $868.0K | |
| Other Current Assets | $54.0K | $84.0K | $81.0K | $276.0K | $367.0K | $694.0K | $688.0K | $68.0K | |
| Current Assets | $23M | $44M | $77M | $94M | $112M | $138M | $106M | $73M | |
| PP&E (Net) | $595.0K | $315.0K | $234.0K | $393.0K | $263.0K | $427.0K | $709.0K | $283.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $378.0K | |
| Accum. Depreciation | $844.0K | $639.0K | $507.0K | $185.0K | $959.0K | $615.0K | $283.0K | $95.0K | |
| Goodwill | · | $0 | $18M | $0 | $0 | · | · | · | |
| Intangibles | $68M | $60M | $64M | $6M | $0 | · | · | · | |
| Other Non-current Assets | $2M | $10M | $9M | $0 | $194.0K | $39.0K | $217.0K | $10.0K | |
| Total Assets | $94M | $114M | $168M | $104M | $133M | $189M | $124M | $73M | |
| Accounts Payable | $2M | $3M | $2M | $570.0K | $5M | $4M | $3M | $495.0K | |
| Accrued Liabilities | $11M | $4M | $3M | $2M | $9M | $13M | $6M | $962.0K | |
| Current Liabilities | $43M | $7M | $10M | $3M | $14M | $17M | $9M | $1M | |
| Capital Leases | $330.0K | $394.0K | $321.0K | $0 | $420.0K | $208.0K | · | · | |
| Deferred Tax | $0 | $5M | $5M | $248.0K | $0 | · | · | · | |
| Other Non-current Liabilities | $2M | $685.0K | $587.0K | $0 | · | · | · | · | |
| Total Liabilities | $129M | $84M | $83M | $3M | $15M | $17M | $9M | $1M | |
| Long-term Debt | $0 | $14M | $13M | $0 | · | · | · | · | |
| Total Debt | $18M | · | · | · | · | · | · | · | |
| Common Stock | $0 | $44.0K | $43.0K | $36.0K | $30.0K | $29.0K | $27.0K | $3.0K | |
| Paid-in Capital | $419M | $407M | · | · | · | · | · | · | |
| Retained Earnings | $-460M | $-376M | $-320M | $-288M | $-237M | $-147M | $-70M | $-33M | |
| AOCI | $6M | $-35.0K | $3M | $-289.0K | $-79.0K | $313.0K | $60.0K | $-49.0K | |
| Stockholders' Equity | $-36M | $30M | $85M | $101M | $119M | $172M | $115M | $-33M | |
| Liabilities + Equity | $94M | $114M | $168M | $104M | $133M | $189M | $124M | $73M | |
| Shares Outstanding | 278,627 | 220,009 | 42,973,215 | 36,136,480 | 30,074,412 | 29,543,222 | 26,869,413 | 3,412,366 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $142.0K | $186.0K | $322.0K | $204.0K | $344.0K | $332.0K | $188.0K | $51.0K | |
| Stock-based Comp | $5M | $5M | $5M | $17M | $30M | $14M | $2M | $155.0K | |
| Deferred Tax | $-6M | $-45.0K | $-258.0K | $284.0K | · | · | · | · | |
| Operating Cash Flow | $-41M | $-32M | $-18M | $-44M | $-63M | $-51M | $-33M | $-12M | |
| CapEx | $352.0K | $257.0K | $160.0K | $133.0K | $180.0K | $52.0K | $55.0K | $212.0K | |
| Investing Cash Flow | $23M | $22M | $-6M | $18M | $59M | $-52M | $-18M | $-47M | |
| Stock Issued | · | · | $0 | $608.0K | $0 | · | · | · | |
| Net Stock Activity | · | · | $0 | $608.0K | · | · | · | · | |
| Financing Cash Flow | $18M | $-5M | $143.0K | $707.0K | $7M | $119M | $77M | $76M | |
| Net Change in Cash | $-403.0K | $-15M | $-24M | $-25M | $3M | $16M | $26M | · | |
| Free Cash Flow | $-42M | $-32M | $-18M | $-44M | $-63M | $-51M | $-33M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -80.8% | -40.2% | -23.1% | -43.6% | -55.8% | -49.0% | -37.5% | · | |
| ROE | 700.5% | -151.4% | -37.3% | -50.4% | -71.6% | -42.7% | -30.5% | · | |
| ROIC | 341.4% | -190.3% | -40.9% | -51.4% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 6.1 | 8.1 | 30.5 | 7.9 | 8.1 | 11.9 | · | |
| Quick Ratio | 0.1 | 5.6 | 7.8 | 29.4 | 7.5 | 7.9 | 5.8 | · | |
| Debt / Equity | -0.5 | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.64 | $0.69 | $1.98 | $2.78 | $3.94 | $5.83 | $4.30 | · | |
| Cash Flow / Share | $-0.83 | $-0.74 | $-0.49 | $-1.31 | · | · | · | · | |
| Cash / Share | $0.10 | $0.93 | $1.75 | $2.50 | $3.55 | $4.53 | $1.91 | · | |
| EPS (TTM) | $-1.68 | $-1.31 | $-0.84 | $-1.54 | $-3.03 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-84M | $-57M | $-31M | $-52M | $-90M | $-77M | $-37M | · | |
| Market Cap | $187M | $82M | $45M | $23M | $380M | $821M | $1.51B | · | |
| Enterprise Value | $199M | · | · | · | · | · | · | · | |
| P/E | -2.0 | -1.4 | -1.2 | -0.4 | -4.2 | · | · | · | |
| P/B | -5.2 | 2.7 | 0.5 | 0.2 | 3.2 | 4.8 | 13.1 | · | |
| P / Tangible Book | · | · | 11.9 | 0.2 | 3.2 | 4.8 | · | · | |
| P / Cash Flow | -4.5 | -2.6 | -2.5 | -0.5 | -6.0 | -16.1 | -45.3 | · | |
| P / FCF | -4.5 | -2.6 | -2.4 | -0.5 | -6.0 | -16.1 | -45.3 | · | |
| EV / EBITDA | -3.4 | · | · | · | · | · | · | · | |
| EV / FCF | -4.8 | · | · | · | · | · | · | · | |
| Earnings Yield | -50.1% | -70.0% | -80.0% | -241.8% | -24.0% | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $7M | $13M | $8M | $7M | $8M | $6M | $5M | $4M | $4M | $3M | $1M | $1M | $3M | $3M | $2M | |
| SG&A Expense | $17M | $4M | $4M | $3M | $3M | $5M | $4M | $4M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $80M | $15M | $19M | $13M | $10M | $15M | $12M | $6M | $28M | $11M | $10M | $6M | $6M | $13M | $6M | $8M | |
| Operating Income | $-80M | $-15M | $-19M | $-13M | $-10M | $-15M | $-12M | $-6M | $-28M | $-11M | $-10M | $-6M | $-6M | $-13M | $-6M | $-8M | |
| Interest Income | $584.0K | $160.0K | $227.0K | $300.0K | $311.0K | $406.0K | $536.0K | $683.0K | $823.0K | $887.0K | $1M | $959.0K | $805.0K | $700.0K | $536.0K | $315.0K | |
| Other Non-op | $152.0K | $2M | $660.0K | $-58.0K | $-29.0K | $-87.0K | $-518.0K | $150.0K | $91.0K | $-399.0K | $467.0K | $-216.0K | $-107.0K | $-246.0K | $204.0K | $-616.0K | |
| Pretax Income | · | · | · | · | · | $-15M | · | · | · | $-11M | · | · | · | · | · | · | |
| Income Tax | $75.0K | $-5M | $3M | $-46.0K | $67.0K | $47.0K | $7.0K | $13.0K | $36.0K | $31.0K | $51.0K | $0 | $0 | $-248.0K | $0 | $0 | |
| Net Income | $-75M | $36M | $-39M | $-13M | $-16M | $-15M | $-12M | $-5M | $-28M | $-11M | $-9M | $-5M | $-5M | $-12M | $-6M | $-8M | |
| EPS (Basic) | $-12.31 | $3.60 | $-0.75 | $-0.25 | $-68.75 | $-3.42 | $-0.28 | $-0.13 | $-0.64 | $-0.26 | $-0.21 | $-0.15 | $-0.14 | $-0.34 | $-0.09 | $-0.22 | |
| EPS (Diluted) | $-12.31 | $2.88 | $-0.75 | $-0.25 | $-68.75 | $-3.42 | $-0.28 | $-0.13 | $-0.64 | $-0.26 | $-0.21 | $-0.15 | $-0.14 | $-0.34 | $-0.09 | $-0.22 | |
| Shares (Basic) | 6,132,845 | 9,120,267 | · | 53,951,371 | 233,431 | 4,394,119 | · | 43,164,136 | 43,096,374 | 43,010,212 | · | 36,073,040 | 35,917,592 | 35,855,200 | · | 35,612,749 | |
| Shares (Diluted) | 6,132,845 | 9,190,354 | · | 53,951,371 | 233,431 | 4,394,119 | · | 43,164,136 | 43,096,374 | 43,010,212 | · | 36,073,040 | 35,917,592 | 35,855,200 | · | 35,612,749 | |
| EBITDA | $-80M | $-15M | · | $-13M | $-10M | $-15M | · | $-6M | $-28M | $-11M | · | $-6M | $-6M | $-13M | · | $-8M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $116M | $18M | $6M | $6M | $17M | $8M | $6M | $48M | $59M | $68M | · | $21M | $21M | $42M | · | $22M | |
| Short-term Investments | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $500.0K | · | · | · | · | |
| Prepaid Expense | $7M | $7M | $5M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $2M | $1M | $983.0K | $2M | $4M | $4M | |
| Other Current Assets | $393.0K | $24.0K | $54.0K | $96.0K | $55.0K | $32.0K | $84.0K | $55.0K | $79.0K | $48.0K | $81.0K | $92.0K | $143.0K | $179.0K | $276.0K | $336.0K | |
| Current Assets | $123M | $26M | $23M | $29M | $37M | $34M | $44M | $52M | $63M | $70M | $77M | $85M | $89M | $92M | $94M | $98M | |
| PP&E (Net) | $506.0K | $550.0K | $595.0K | $616.0K | $573.0K | $448.0K | $315.0K | $208.0K | $246.0K | $234.0K | $234.0K | $5.0K | $6.0K | $6.0K | $393.0K | $375.0K | |
| Accum. Depreciation | $882.0K | $856.0K | $844.0K | $807.0K | $777.0K | $691.0K | $639.0K | $667.0K | $566.0K | $530.0K | $507.0K | $13.0K | $12.0K | $12.0K | $185.0K | $159.0K | |
| Goodwill | · | · | · | $0 | · | · | $0 | $0 | $0 | $17M | $18M | $0 | $0 | $0 | $0 | $0 | |
| Intangibles | $0 | $0 | $68M | $68M | $68M | $62M | $60M | $65M | $62M | $62M | $64M | $0 | $0 | $0 | $6M | $6M | |
| Other Non-current Assets | $78.0K | $78.0K | $2M | $12M | $11M | $10M | $10M | $10M | $9M | $8M | $9M | · | · | · | $0 | $17.0K | |
| Total Assets | $124M | $27M | $94M | $110M | $117M | $107M | $114M | $127M | $135M | $159M | $168M | $85M | $89M | $93M | $104M | $110M | |
| Accounts Payable | $5M | $5M | $2M | $3M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $409.0K | $353.0K | $2M | $570.0K | $1M | |
| Accrued Liabilities | $4M | $3M | $11M | $5M | $6M | $5M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $4M | |
| Current Liabilities | $8M | $9M | $43M | $26M | $7M | $8M | $7M | $5M | $10M | $10M | $10M | $2M | $2M | $3M | $3M | $5M | |
| Capital Leases | $0 | $293.0K | $330.0K | $359.0K | $387.0K | $383.0K | $394.0K | $450.0K | $453.0K | $480.0K | $321.0K | · | · | · | $0 | $34.0K | |
| Deferred Tax | · | · | $0 | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $0 | $0 | $0 | $248.0K | $248.0K | |
| Other Non-current Liabilities | $716.0K | $1M | $2M | $778.0K | $745.0K | $716.0K | $685.0K | $643.0K | $609.0K | $599.0K | $587.0K | · | · | · | $0 | · | |
| Total Liabilities | $16M | $11M | $129M | $109M | $105M | $89M | $84M | $82M | $88M | $85M | $83M | $2M | $2M | $3M | $3M | $5M | |
| Long-term Debt | · | · | $0 | $0 | $17M | $15M | $14M | $15M | $14M | $14M | $13M | · | · | · | $0 | · | |
| Total Debt | $0 | $0 | · | $18M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $14.0K | $55.0K | $54.0K | $53.0K | $44.0K | $44.0K | $43.0K | $43.0K | $43.0K | $43.0K | $36.0K | $36.0K | $36.0K | $36.0K | $36.0K | |
| Paid-in Capital | $460M | $436M | $419M | $416M | $413M | $408M | $407M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-500M | $-425M | $-460M | $-421M | $-408M | $-392M | $-376M | $-364M | $-359M | $-331M | $-320M | $-311M | $-305M | $-301M | $-288M | $-283M | |
| AOCI | $4M | $5M | $6M | $6M | $6M | $2M | $-35.0K | $3M | $1M | $2M | $3M | $516.0K | $257.0K | $38.0K | $-289.0K | $-253.0K | |
| Stockholders' Equity | $-35M | $16M | $-36M | $1M | $12M | $19M | $30M | $45M | $47M | $74M | $85M | $83M | $87M | $90M | $101M | $105M | |
| Liabilities + Equity | $124M | $27M | $94M | $110M | $117M | $107M | $114M | $127M | $135M | $159M | $168M | $85M | $89M | $93M | $104M | $110M | |
| Shares Outstanding | 1,017,063 | 13,790,794 | 55,725,291 | 54,494,965 | 53,624,180 | 44,089,142 | 44,001,643 | 43,276,606 | 43,276,606 | 43,215,233 | 42,973,215 | 36,343,632 | 36,327,995 | 36,278,433 | 36,136,480 | 36,130,306 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $41.0K | $36.0K | $39.0K | $36.0K | $35.0K | $32.0K | $16.0K | $86.0K | $44.0K | $40.0K | $304.0K | $0 | $1.0K | $17.0K | $42.0K | $40.0K | |
| Stock-based Comp | $12M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $694.0K | |
| Operating Cash Flow | $-19M | $-8M | $-10M | $-10M | $-11M | $-10M | $-8M | $-7M | $-9M | $-8M | $-6M | $-5M | $-4M | $-4M | $-6M | $-7M | |
| CapEx | $0 | $0 | $4.0K | $74.0K | $126.0K | $148.0K | $133.0K | $46.0K | $39.0K | $39.0K | $24.0K | $0 | $0 | $136.0K | $78.0K | $50.0K | |
| Investing Cash Flow | $8M | $12M | $8M | $-2M | $6M | $11M | $11M | $7M | $-5M | $9M | $5M | $4M | $-20M | $6M | $19M | $-9M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $109M | $9M | $2M | $1M | $14M | $87.0K | $0 | $-5M | $35.0K | $190.0K | $57.0K | $10.0K | $26.0K | $50.0K | $-18.0K | $-5.0K | |
| Net Change in Cash | $98M | $12M | $-643.0K | $-10M | $9M | $2M | $4M | $-5M | $-14M | $1M | $-880.0K | $-1M | $-24M | $2M | $13M | $-15M | |
| Free Cash Flow | · | $-8M | · | · | · | $-10M | · | · | · | $-8M | · | · | · | $-4M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -62.6% | 53.7% | · | -11.4% | -12.7% | -11.3% | · | -5.2% | -24.8% | -8.8% | · | -5.5% | -4.7% | -11.7% | · | -6.2% | |
| ROE | 640.0% | 209.7% | · | -58.5% | -54.7% | -32.4% | · | -8.6% | -41.4% | -13.6% | · | -5.7% | -4.9% | -12.5% | · | -6.7% | |
| ROIC | · | · | · | · | · | -80.2% | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.5 | 2.9 | · | 1.1 | 5.0 | 4.0 | · | 9.5 | 6.1 | 7.2 | · | 37.8 | 45.4 | 29.7 | · | 19.9 | |
| Quick Ratio | 13.6 | 2.1 | · | 0.2 | 2.3 | 0.9 | · | 8.8 | 5.8 | 6.9 | · | 9.5 | 10.6 | 13.6 | · | 4.4 | |
| Debt / Equity | 0.0 | 0.0 | · | 16.5 | · | · | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-34.73 | $1.14 | · | $0.02 | $0.22 | $0.42 | · | $1.04 | $1.09 | $1.72 | · | $2.29 | $2.39 | $2.49 | · | $2.89 | |
| Cash Flow / Share | · | $-0.83 | · | · | · | $-0.22 | · | · | · | $-0.19 | · | · | · | $-0.10 | · | · | |
| Cash / Share | $114.04 | $1.32 | · | $0.12 | $0.31 | $0.18 | · | $1.10 | $1.37 | $1.57 | · | $0.57 | $0.57 | $1.17 | · | $0.60 | |
| EPS (TTM) | $-10.43 | $-66.87 | · | $-72.70 | $-72.58 | $-4.47 | · | $-1.24 | $-1.26 | $-0.76 | · | $-0.72 | $-0.79 | $-1.16 | · | $-2.23 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-92M | $-33M | · | $-57M | $-49M | $-61M | · | $-53M | $-53M | $-30M | · | $-28M | $-31M | $-42M | · | $-70M | |
| Market Cap | $19M | $1M | · | $89M | $88M | $59M | · | $34M | $32M | $46M | · | $41M | $55M | $57M | · | $48M | |
| Enterprise Value | $-97M | $-17M | · | $100M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.7 | -0.0 | · | -0.0 | -0.0 | -0.3 | · | -0.6 | -0.6 | -1.4 | · | -1.6 | -1.9 | -1.3 | · | -0.6 | |
| P/B | -0.5 | 0.1 | · | 83.9 | 7.5 | 3.2 | · | 0.7 | 0.7 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| P / Tangible Book | · | 0.1 | · | · | · | · | · | · | · | · | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| P / Cash Flow | · | -0.2 | · | · | · | -6.1 | · | · | · | -5.5 | · | · | · | -15.9 | · | · | |
| Earnings Yield | -57.3% | -66207.9% | · | -4460.1% | -4398.8% | -336.1% | · | -159.8% | -168.0% | -71.7% | · | -64.3% | -52.5% | -74.4% | · | -167.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-84M | $-57M | $-31M | $-52M | $-90M |
| EPS Diluido | $-1.68 | $-1.31 | $-0.84 | $-1.54 | $-3.03 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | -0.5 | · | · | · | · |
| Ratio corriente | 0.5 | 6.1 | 8.1 | 30.5 | 7.9 |
| Ratio Rápido | 0.1 | 5.6 | 7.8 | 29.4 | 7.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-42M | $-32M | $-18M | $-44M | $-63M |
Propietarios institucionales (13F) 2 declarantes · $7.1M total · A fecha de 31 de diciembre de 2025
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
2
Valor en tenencia
$7.1M
Nuevas posiciones
15
Posiciones cerradas
35
Actividad institucional — Q1 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 15 (-11 vs trimestre anterior) | 35 (+31 vs trimestre anterior) | 8 (-13 vs trimestre anterior) | 12 (+7 vs trimestre anterior) | -5.2M |
Comparado con Q4 2025. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6 981 450 | 2 084 015 | 98,72% | Acciones |
| TWO SIGMA ADVISERS, LP | $90 785 | 27 100 | 1,28% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| David A. Lamond | 13 de noviembre de 2024 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 24 insiders · 14 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Dirk Thye | CEO and CMO | 23 de enero de 2026 A | 739 885 | 0 | 0 | $0 |
| Christopher P. Lowe | Interim CEO, COO & CFO | 3 de marzo de 2022 A | 265 000 | 0 | 0 | $0 |
| Casey Lynch | Chief Executive Officer | 3 de enero de 2022 A | 109 895 | 0 | 0 | $0 |
| Charles S. Ryan | President | 23 de enero de 2026 A | 130 009 | 0 | 0 | $0 |
| Brendan Hannah | CBO, COO & CCO | 23 de enero de 2026 A | 361 827 | 0 | 0 | $0 |
| Brigette Roberts | Chief Corp. Affairs Officer | 18 de mayo de 2026 A | · | 0 | 0 | $0 |
| Guenter Janhofer | Chief Scientific Officer | 23 de octubre de 2023 A | · | 0 | 0 | $0 |
| Ted Monohon | Chief Accounting Officer & VP | 6 de marzo de 2023 S | 27 440 | 0 | 0 | $0 |
| Karen L. Smith | Chief Medical Officer | 1 de febrero de 2023 A | 194 690 | 0 | 0 | $0 |
| Leslie Holsinger | EVP, Preclinical Development | 6 de junio de 2022 F | 148 080 | 0 | 0 | $0 |
| Caryn Gordon Mcdowell | Chief Legal & Adm. Officer | 6 de junio de 2022 S | 122 500 | 0 | 0 | $0 |
| Michael J. Detke | Chief Medical Officer | 3 de marzo de 2022 A | 140 000 | 0 | 0 | $0 |
| Stephen S. Dominy | Chief Scientific Officer | 3 de enero de 2022 A | 1 217 086 | 0 | 0 | $0 |
| Kristen Gafric | SVP, Legal & Administration | 6 de febrero de 2020 A | · | 0 | 0 | $0 |
| David Lamond | Consejero | 11 de junio de 2026 A | 2 347 545 | 0 | 0 | $0 |
| Christopher J. Senner | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| June Bray | Consejero | 2 de enero de 2026 A | · | 0 | 0 | $0 |
| Margaret Mcloughlin | Consejero | 2 de enero de 2026 A | 8 000 | 0 | 0 | $0 |
| Luca Benatti | Consejero | 26 de diciembre de 2025 S | 39 179 | 0 | 1 | $-173 500 |
| Rajiv Patni | Consejero | 4 de junio de 2025 A | · | 0 | 0 | $0 |
| Una S Ryan | Consejero | 4 de junio de 2025 A | 2 875 | 0 | 0 | $0 |
| Philip S Low | Consejero | 19 de mayo de 2022 A | 63 974 | 0 | 0 | $0 |
| Marwan Sabbagh | Consejero | 14 de marzo de 2022 A | · | 0 | 0 | $0 |
| Kevin Young | Consejero | 8 de junio de 2020 A | 30 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12 044 SH | 19 de agosto de 2026 | Diario |
QNCX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$70.00
+139,7%
4 30,8%
Compra fuerte
5 38,5%
Compra
4 30,8%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-10-04Objetivo medio $75.43 +158,3%
← Por Debajo de Todos los Objetivos
Precio Actual $29.20
Mín$65.00
Media$75.43
Máx$98.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| QNCX | $187M | -2.0 | · | · | 700.5% | · |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | · |
| ELUT | · | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| BYSI | · | · | · | · | 3.1% | · |
| ABVC | $53M | -5.5 | 234.3% | · | -128.2% | · |
| MCRB | $142M | 23.2 | · | 721.9% | 14.8% | · |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 14, 2026